• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2101036 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs Supplementary Application 2021-04-12 Gilead Sciences Ireland Uc view
JYHB2400604 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs Supplementary Application 2024-11-19 Gilead Sciences Ireland Uc view
JYHB2101067 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs Supplementary Application 2021-04-27 Gilead Sciences Ireland Uc view
JYHZ2300440 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs License Renew 2023-11-24 view
JYHB2300646 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs Supplementary Application 2023-11-11 Gilead Sciences Ireland Uc view
JYHB1901379 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs Supplementary Application 2019-11-20 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Certificate Issued 2020-02-05 view
JYHB2001095 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs Supplementary Application 2020-07-06 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Certificate Issued 2021-03-25 view
JYHB2001044 比克恩丙诺片 bictegravir sodium;emtricitabine;tenofovir alafenamide fumarate Tablet Chemical Drugs Supplementary Application 2020-07-06 吉利德(上海)医药科技有限公司 Gilead (Shanghai) Pharmaceutical Technology Co Ltd Certificate Issued 2020-09-14 view